Overview

Massachusetts General Hospital main entrance
The main entrance at Mass General.

Massachusetts General Hospital is a 1,000-bed, academic teaching hospital in Boston, MA. It is the largest hospital in New England, and the third oldest in the United States. Consistently ranked as one of the top hospitals in the nation by US News & World Report, Mass General’s history and achievements have earned it a reputation as one of the foremost medical centers in the world for centuries, dating as far back as 1846, the first public demonstration of the use of ether as an anesthetic during surgery took place in the Mass General Ether Dome. Mass General is affiliated with Harvard Medical School and conducts the largest hospital-based research program in the U.S.

Department of Pharmacy

Established in 1845, the Mass General Department of Pharmacy provides innovative and comprehensive direct patient care and operational services to the inpatient hospital and numerous outpatient clinics.

The Department of Pharmacy encompasses a staff of approximately 400 fulltime employees, a $350 million annual drug budget, and 15 locations including the Gray Main Inpatient Pharmacy, Jackson Compounding Pharmacy, Lunder Inpatient Oncology Satellite, Wang Outpatient Pharmacy, Yawkey Ambulatory Oncology Infusion Pharmacy, General and Oncology Clinical Trials Pharmacy, as well as numerous outpatient and ambulatory oncology pharmacies off-campus. Over 6 million medication doses are dispensed annually and are supported by medication carousels, IV robotics, anesthesia workstations, and automated dispensing cabinets. The hospital has a fully implemented electronic medical record across the institution. Pharmacists are involved in complex medical management, integrated into multidisciplinary teams and provide services such as therapeutic drug monitoring, patient counseling, drug information, medication reconciliation and acute emergency response.

Pharmacy Residency Training

Mass General Ether Dome
The Ether Dome at Mass General.

Our mission is to provide a dynamic, goal-oriented environment to develop a well-rounded clinical expert, educator and leader and to assure each resident is thoroughly trained in the provision of individualized direct patient care, clinical and didactic teaching, practice-based research, and patient-centric pharmacy leadership. The Mass General Pharmacy Residency Programs are committed to adhering to the accreditation standards set forth by the American Society of Health-System Pharmacists, and therefore strive to meet and exceed those standards.

A multitude of clinical learning experiences are offered to provide the knowledge and skills necessary to develop a resident into an independent practitioner. Under the direction and guidance of expert-level clinical pharmacists, residents will ultimately assume ownership and responsibility of their patients’ pharmaceutical care and become vital members of medical teams. In addition, numerous longitudinal expectations will allow residents to experience interdisciplinary teamwork, pharmacy operations, pharmacy practice management, clinical trials and process improvement. At Mass General, we take pride in being able to effectively place every residents’ professional objectives at the center of their training, thereby enabling them to excel in a variety of career paths. We instill passion for the practice of pharmacy and empathy for patient care such that each resident is also committed to the advancement of the profession.

Curriculum

The Massachusetts General Hospital Department of Pharmacy offers the following Pharmacy Residency programs:

Graduate Pharmacy Education

All of the Pharmacy Residency Programs at Mass General are unified together as Graduate Pharmacy Education. Collectively, these criteria-based, post-graduate training experiences are designed to develop trainees into autonomous clinicians with the skills needed to lead patient-specific programs in acute care practice settings.

While on clinical service, post-graduate year one (PGY1) and post-graduate year two (PGY2) residents collaborate and serve as the primary pharmacists for their assigned patients. As members of integrated healthcare teams, residents work cooperatively with other providers to deliver safe medication therapy and achieve optimal outcomes.

Residents participate in multidisciplinary bedside rounds, develop patient care plans, and optimize medication therapy. In all programs, residents develop skills in clinical and didactic teaching, research methodology, critical thinking, and pharmacy practice leadership.

Learning Experiences

  • Required core learning experiences
  • Elective learning experiences chosen based on resident’s interest
  • Longitudinal learning experiences

Presentations

  • ACPE-accredited Clinical Seminar
  • Pharmacy Grand Rounds
  • Journal club and case presentations
  • Multidisciplinary in-services

Research

  • Longitudinal research project
  • Guidance from mentor(s) and the Residency Research Committee
  • Poster presentation at the Vizient Council Meeting and/or the ASHP Midyear Clinical Meeting and Exhibition
  • Platform presentation at the Eastern States Conference for Pharmacy Residents and Preceptors

Residents Teaching Seminar

  • Optional monthly teaching seminar series coordinated for Massachusetts-based pharmacy residents
  • Teaching certificate issued in collaboration with Massachusetts College of Pharmacy and Health Sciences University

Pharmacy Practice Experience

  • Decentral pharmacy practice experience (PGY1 and PGY2 pharmacy residents)
  • Central pharmacy practice experience (PGY1 pharmacy residents)
  • Acute emergency response with ACLS certification
  • Cystic fibrosis-aminoglycoside pharmacokinetics consult service

Leadership Opportunities

  • Residency officer positions and resident-run committees
  • Pharmacy & Therapeutics Committee
  • ASHP Visiting Leaders Program
  • ASHP Whitney Reception
  • John W. Webb Lecture

Meetings and Conferences

  • ASHP Midyear Clinical Meeting and Exhibition
  • Vizient Pharmacy Council Meeting
  • MSHP Annual Meeting
  • Eastern States Conference for Pharmacy Residents and Preceptors
  • Other (with approval from Residency Program Director, Director of Graduate Pharmacy Education and Chief Pharmacy Officer)

Benefits

  • Competitive stipend: PGY1: $52,000 PGY2: $55,000
  • Health insurance options
  • Vacation days, paid holidays and sick time
  • Professional materials (laptop, pager, lab coat, office space, drug information resources, etc.)
  • Travel reimbursement for approved conferences
  • Massachusetts Society of Health-System Pharmacists membership
  • Discounted subway/train passes
  • Discounted health club membership
  • “MGH Perks” for various activities in the New England area

Faculty

Full Listing of Graduate Pharmacy Education Preceptors

Residency Leadership

  • Dr. John Marshall, PharmD, BCPS, BCCCP, FCCM

    Dr. John Marshall, PharmD, BCPS, BCCCP, FCCM serves as the Director of Graduate Pharmacy Education at Massachusetts General Hospital. John is originally from Reno, Nevada, and attended Gonzaga University and The University of Texas at Austin, where he received his Doctor of Pharmacy. He completed a PGY 1 residency at The University of Massachusetts Memorial Medical Center in Worcester, MA. Dr. Marshall has held positions as a critical care pharmacist, pharmacy faculty, and pharmacy services administrator prior to MGH. He is currently the Director of Clinical Pharmacy Services at Massachusetts General Hospital.

  • Dr. Christopher Fortier, PharmD, FASHP

    Dr. Christopher Fortier, PharmD, FASHP serves as the Chief Pharmacy Officer and Residency Director for the PGY-1/PGY-2 HSPA Residency Program at Massachusetts General Hospital. Dr. Fortier received his Doctor of Pharmacy degree from the University of Connecticut and completed both a PGY-1 Practice Residency and a PGY-2 Health-System Pharmacy Administration Residency at the Medical University of South Carolina Medical Center. Additionally, Chris serves as an Adjunct Associate Professor at the University of Connecticut School of Pharmacy, Northeastern University School of Pharmacy, and the MCPHS.

  • Dr. Russel J. Roberts PharmD, BCCCP, FCCM

    Dr. Russel J. Roberts PharmD, BCCCP, FCCM serves as the Residency Director for the PGY-2 Critical Care Pharmacy Residency Program at Massachusetts General Hospital. Russel is originally from St. Louis, MO, and graduated from St. Louis University with a Bachelor’s degree in chemistry and received his Doctor of Pharmacy degree from St. Louis College of Pharmacy in 2004. Russel completed an Internal Medicine Specialty residency at Forest Park Hospital in St. Louis, MO. He then went on to complete a two-year critical care pharmacy fellowship at Tufts Medical Center in Boston, MA. Russel worked for about 8 years as a Senior Clinical Pharmacy Specialist in the ICU at Tufts Medical Center and is currently the Clinical Pharmacy Manager overseeing Cardiology, Critical Care and Pediatric Services at Massachusetts General Hospital. Russel is board certified in critical care pharmacotherapy (BCCCP) and is a fellow of the American College of Critical Care Medicine.

  • Dr. Ramy Elshaboury, PharmD, BCPS-AQ ID

    Dr. Ramy Elshaboury, PharmD, BCPS-AQ ID serves as the Residency Director for the Infectious Diseases PGY2 Program at Massachusetts General Hospital. He received his Doctor of Pharmacy degree from the University of Minnesota – Twin Cities in 2011. Dr. Elshaboury completed a PGY1 and ID PGY2 residencies at Abbott Northwestern Hospital (part of Allina Health) in Minneapolis, MN. He is currently the Clinical Pharmacy Manager for Infectious Diseases, Transplant and Surgery pharmacy services at Massachusetts General Hospital.

  • Dr. Bryan Hayes, PharmD, DABAT, FAACT, FASHP

    Dr. Bryan Hayes, PharmD, DABAT, FAACT, FASHP serves as the Director for the PGY-2 Emergency Medicine Pharmacy Residency Program at Massachusetts General Hospital. Bryan is originally from Coventry, RI, and graduated from Worcester Polytechnic Institute with a Bachelor of Science in Chemistry degree. He received his Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Health Sciences in 2005. Bryan completed a PGY-1 Pharmacy Residency at UMass Memorial Medical Center in Worcester, MA in 2006 and a Clinical Toxicology Fellowship at the Maryland Poison Center/University of Maryland School of Pharmacy in Baltimore, MD, in 2008. He worked at the University of Maryland Medical Center from 2008-2016 and is currently the Clinical Manager for Emergency Medicine and Overnight Pharmacy Services at Massachusetts General Hospital. Dr. Hayes is board-certified in Clinical Toxicology and holds an Assistant Professor of Emergency Medicine appointment at Harvard Medical School.

  • Dr. Gayle Blouin, PharmD, BCOP

    Dr. Gayle Blouin, PharmD, BCOP serves as the Residency Director for the PGY2 Oncology Program at Massachusetts General Hospital. Gayle is originally from Fall River, MA. She graduated from Northeastern University with a Bachelor of Science in Pharmacy and received her Doctor of Pharmacy degree from MCPHS in Boston. Gayle completed a PGY2 Oncology/Palliative Care residency at the Dana-Farber Cancer Institute/Brigham Women’s Hospital in Boston, MA. Gayle has worked at Massachusetts General Hospital since 2001 and is currently the Clinical Pharmacy Manager for Ambulatory Oncology.

  • Dr. Christin Rogers (Marks), PharmD, BCPS, FCCP, FAST

    Dr. Christin Rogers (Marks), PharmD, BCPS, FCCP, FAST serves as the Residency Director for the Transplant Pharmacy PGY2 Residency Program at Massachusetts General Hospital. Christin is originally from West Sand Lake, New York. She received her Doctor of Pharmacy degree from Northeastern University in Boston, MA. Christin completed her PGY1 residency at The University of Colorado Hospital in Denver, CO and her Transplant Pharmacy PGY2 and Research Fellowship at the University of Cincinnati in Cincinnati, OH. She previously worked as the Clinical Coordinator for Solid organ Transplant at Beth Israel Deaconesses Medical Center for 14 years and is currently the Senior Clinical Coordinator for Transplant Pharmacy Services at Massachusetts General Hospital.

  • Dr. Tasleem Spracklin PharmD, BCPS

    Dr. Tasleem Spracklin PharmD, BCPS serves as the Residency Director for the PGY1 Program at Massachusetts General Hospital. Tasleem is originally from North Bergen, NJ, and received her Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Health Sciences in Boston, MA. Tasleem completed a PGY1 residency at Huntington Veterans Affairs Medical Center in Huntington, WV. Tasleem previously worked at Froedtert Hospital in Milwaukee, WI and is currently a Clinical Medicine Pharmacist/Meds to Beds Lead Specialist at Massachusetts General Hospital.

  • Dr. Kristy Phillips, PharmD, BCPS, BCCPS

    Dr. Kristy Phillips, PharmD, BCPS, BCCPS serves as the Coordinator for the PGY2 Critical Care Residency Program at Massachusetts General Hospital. Kristy is originally from Syracuse, New York, and graduated from Northeastern University with her Doctor of Pharmacy degree in 2010. Kristy completed a PGY1 Pharmacy residency at Kingsbrook Jewish Medical Center in Brooklyn, NY. She is board certified in Pharmacotherapy (BCPS) and Critical Care Pharmacotherapy (BCCCP). Kristy is currently a Clinical Pharmacist in the Medical ICU at Massachusetts General Hospital.

  • Dr. Lanting Fuh, PharmD, BCPS

    Dr. Lanting Fuh, PharmD, BCPS serves as the Residency Coordinator for the Emergency Medicine PGY2 Pharmacy Residency Program at Massachusetts General Hospital. She is originally from Glastonbury, Connecticut, and received her Doctor of Pharmacy degree from the University of Connecticut. Lanting completed a PGY1 Pharmacy Practice residency at Denver Health Medical Center and PGY2 Emergency Medicine Pharmacy Residency at The Ohio State University Wexner Medical Center. She is currently an attending clinical pharmacist of emergency medicine at Massachusetts General Hospital. Her professional interests include anticoagulation reversal, cardiac arrest/resuscitation, emergency preparedness, and burnout prevention.

  • Dr. Ronak Gandhi, PharmD, BCPS

    Dr. Ronak Gandhi, PharmD, BCPS serves as the Residency Coordinator for the PGY-1 and PGY-2 Infectious Diseases Program at Massachusetts General Hospital. Dr. Gandhi is originally from Boston, MA and graduated from Northeastern University with his Doctor of Pharmacy degree in 2013. Dr. Gandhi completed a PGY-1 Pharmacy Practice Residency at Detroit Medical Center in 2014 and a PGY-2 Infectious Diseases Residency at the University of Arizona in 2015. Dr. Gandhi is currently the Clinical Pharmacist-Infectious Diseases at Massachusetts General Hospital.

  • Dr. Jonathan H. Sin, PharmD, BCPS

    Dr. Jonathan H. Sin, PharmD, BCPS serves as the Residency Coordinator for the PGY1 Program at Massachusetts General Hospital. Jonathan is originally from Brooklyn, NY, and received his Doctor of Pharmacy degree from St. John’s University in Queens, NY. Jonathan completed a PGY1 residency at New York-Presbyterian Hospital and a PGY2 specialty residency in critical care at Massachusetts General Hospital. Jonathan is currently a Clinical Pharmacist in the Surgical/Trauma Intensive Care Unit at Massachusetts General Hospital.

  • Dr. Laura Meleis, PharmD, MS, BCPS

    Dr. Laura Meleis, PharmD, MS, BCPS serves as the Residency Coordinator for the PGY-1/PGY-2 HSPA Residency Program at Massachusetts General Hospital. Laura is originally from Florida where she received her Bachelor of Science in Health Sciences from the University of Central Florida. She received her Doctor of Pharmacy degree from the University of North Carolina Eshelman School of Pharmacy and completed her PGY-1/PGY-2 Health System Pharmacy Administration Residency Program at Duke University Hospital in Durham, North Carolina with a Master of Science Degree specializing in Pharmacy Administration from the UNC Eshelman School of Pharmacy. She is currently the Assistant Director of Quality, Compliance, and Regulatory Affairs at Massachusetts General Hospital.

  • Dr. Thais Gift, PharmD, BCPS

    Dr. Thais Gift, PharmD, BCPS, serves as the Residency Coordinator for the PGY2 Solid Organ Transplant Program at Massachusetts General Hospital. Thais is originally from Puerto Rico where she received her Doctor of Pharmacy degree from the University of Puerto Rico, Medical Sciences Campus in San Juan, Puerto Rico. She completed a PGY1 Pharmacy Residency Program at Massachusetts General Hospital in Boston, Massachusetts. She is currently a Cardiothoracic Solid Organ Transplant Pharmacist at Massachusetts General Hospital.

  • Dr. Thu Oanh Dang, PharmD, BCOP

    Dr. Thu Oanh Dang, PharmD, BCOP serves as the Residency Coordinator for the PGY-2 Oncology Residency Program at Massachusetts General Hospital. Thu is originally from Vietnam and lived in Seattle followed by New York City before Massachusetts. She received her Bachelor of Science in Biochemistry and Doctor of Pharmacy degrees from the University of Washington in Seattle, WA. She completed a PGY-1 residency at the Franciscan Health System in Tacoma, WA and PGY-2 in Oncology at the University of Kansas Medical Center in Kansas City, KS. She worked at Memorial Sloan Kettering Cancer in New York, NY as a clinical oncology pharmacy specialist for eight years and is currently the oncology pharmacy specialist at Massachusetts General Hospital.

Resident Community

Who We Are

Each year, the Mass General Department of Pharmacy recruits top candidates for the Pharmacy Residency Programs. Our residents come from all across the United States, and bring diverse backgrounds and perspectives to the department and institution. Our clinical pharmacy preceptors are experts in their chosen specialty and are dedicated to the continual growth and development of our residents and programs.

current residents
Our PGY1 and PGY2 residents have diverse backgrounds and training. Learn more about our current residents.

Residency Activities

  • Resident welcome outing
  • Massachusetts Society of Health System Pharmacists (MSHP) sunset dinner cruise
  • Dinner celebration at American Society of Health System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition
  • Department of Pharmacy holiday party
  • Residency graduation ceremony
  • Resident Professional Development Experience (off-campus visit)

Life in Boston

boston skyline

As a Mass General resident, you will be based in Boston, home of the Red Sox, excellent clam chowder, Dunkin’ Donuts, and some of the nation’s oldest historical attractions. Mass General’s main campus is located in Boston’s historic Beacon Hill, known for its characteristic brownstone buildings and brick sidewalks. Explore the boutiques and eateries on Charles Street and stroll along the Charles River Esplanade. Head over to Newbury Street for high-end shopping. For history buffs, the Freedom Trail takes you to the site of the Boston Massacre, Paul Revere’s house and Faneuil Hall. Just across the Charles River is the city of Cambridge, home to world-renowned institutions Harvard University and the Massachusetts Institute of Technology (MIT).

PGY-1 Residents

  • Shuroug Alowais

    Dr. Alowais is from Riyadh, Saudi Arabia and graduated from South Carolina College of Pharmacy at University of South Carolina. Her practice interests include infectious diseases, cardiology, and oncology.  She enjoys traveling, eating chocolates, and spending time with her family.  Dr. Alowais plans to pursue a PGY-2 residency upon the completion of her PGY-1. 

  • Katherine Ciampa

    Dr. Ciampa is from Arlington, Virginia and obtained her undergraduate degree from the University of Virginia and graduated from Virginia Commonwealth University School of Pharmacy. Her practice interests include emergency medicine and critical care. She enjoys traveling, reading, trying new foods, and drinking lots of coffee.  Dr. Ciampa plans to complete a PGY2 after completion of the residency year. 

  • Lily Jia

    Dr. Jia is from Midlothian, Virginia and obtained her undergraduate degree from the University of Virginia and graduated from Virginia Commonwealth University School of Pharmacy. Her practice interests include hematology and oncology.  She enjoys hiking, turning car rides into carpool karaoke, and spending quality time with family and friends.  Dr. Jia plans to pursue a PGY-2 in her field of interest after completion of this residency year. 

  • Jenna Lam

    Dr. Lam is from Sacramento, California and obtained undergraduate degrees in Molecular & Cell Biology and Political Economy from UC Berkeley. She graduated from UCSF for pharmacy school. Her practice interests include critical care, infectious diseases, and hematology/oncology. She enjoys working out/yoga/indoor cycling, hiking, and reading a good book! Dr. Lam plans to pursue a fellowship after completion of the residency year.

  • Katie McCrink

    Dr. McCrink is from Miami, FL and obtained her Bachelor of Science from Florida State University and graduated from Nova Southeastern University College of Pharmacy. Her practice interests include both adult and pediatric infectious disease and antimicrobial stewardship. She enjoys yelping, singing, running, event planning, and relaxing by the water. Dr. McCrink plans to pursue a PGY-2 residency in her area of interest after completion of the residency year.

  • Alexander Miller

    Dr. Miller is from Atlanta, GA and obtained his degree from Northeastern University School of Pharmacy. His practice interests include emergency medicine and critical care.  He enjoys coffee, cycling, and cooking.  Dr. Miller plans to pursue a PGY-2 in emergency medicine after completion of the residency year.

  • Shivali Patel

    Dr. Patel is from Rochester, NY and graduated from the Philadelphia College of Pharmacy. Her practice interests include drug information, medication safety, and infectious diseases. She enjoys traveling, trying new foods, and exploring Boston. Dr. Patel plans to pursue a PGY-2 in her area of interest after completion of her PGY-1.

  • Sarah Yun

    Dr. Yun is from North Carolina and graduated from the University of North Carolina Eshelman School of Pharmacy. Her current practice interest is in solid organ transplant. She enjoys cooking, baking, and de-stressing at Sephora. Dr. Yun plans to pursue a PGY-2 in solid organ transplant upon completion of her PGY-1. 

PGY1/2 Health System Administration Pharmacy Residency

  • Felicia Britt

    Dr. Felicia Britt is from Star, North Carolina and obtained both her undergraduate and Doctor of Pharmacy degrees from the University of North Carolina at Chapel Hill and is continuing her studies as a candidate for degree of Master of Science in Pharmaceutical Sciences with specialization in health-system pharmacy administration from the UNC Eshelman School of Pharmacy during her time as a resident.  Her practice interests include ambulatory care service expansion, specialty pharmacy, and retail operations. She enjoys exploring Boston, running, and travelling. Dr. Britt plans to pursue a career in pharmacy administration at an academic medical center after completion of her residency. 

PGY2 Residents

  • Meagan Adamsick

    Dr. Adamsick is from Mundelein, IL and obtained her PharmD from the University of Iowa College of Pharmacy. She completed her PGY1 at UW Health in Madison, Wisconsin. Her practice interests include antimicrobial stewardship, antibiotic resistance and antibiotic allergies. She enjoys discovering new restaurants and exploring Boston with family and friends. She plans to work as an Infectious Diseases pharmacist after completion of the residency year.

  • Michael Griggs

    Dr. Griggs is from Lebanon, OH and graduated from The Ohio State University College of Pharmacy.  He completed his PGY-1 pharmacy practice residency at Massachusetts General Hospital. His practice interests include shock, trauma, sedation/analgesia and sleep.  He enjoys photography, drinking coffee and playing golf. Dr. Griggs plans to work as an ICU specialist and conduct outcomes based research upon completion of the residency year.  

  • Michael O’Brien

    Dr. O’Brien is from West Union, IA and graduated from the University of Iowa College of Pharmacy. He completed his PGY-1 residency at Massachusetts General Hospital in Boston, MA. His practice interests include toxicology, emergency preparedness, and resuscitation. He enjoys traveling, outdoor activities, and spending time with friends and family. Dr. O’Brien plans to work as an emergency medicine clinical specialist at a large academic medical center with opportunities for teaching and research.

Listing of MGH Pharmacy Residency Alumni

How to Apply

Applicants for PGY1 and PGY2 programs must possess a Doctor of Pharmacy (PharmD) degree and be eligible for immediate licensure by the Massachusetts Board of Registration in Pharmacy. Successful completion of an ASHP-accredited PGY1 Pharmacy Residency is required for those applying for the PGY2 programs. Previous experience in pharmacy practice, a sound academic record and other scholarly and leadership activities are also important considerations.

Applications for all programs should be submitted via PhORCAS and must include:

  • Completed application
  • Formal Letter of Intent
  • Curriculum Vitae
  • Official pharmacy school transcripts and undergraduate transcripts (if applicable)
  • Three standardized references completed via PhORCAS.

The deadline for receipt of a completed PhORCAS application is December 31. After applications are reviewed, qualified candidates will be contacted to schedule an on-site interview in Boston, Massachusetts. All of the Pharmacy Residency Programs at Mass General participate in the ASHP Resident Matching Program.

International applicants who have completed a pharmacist training program affiliated with MCPHS University may submit an application to the International PGY1 Pharmacy Residency Program. The completed application must include all the items as indicated above. Applicants must register for the ASHP Resident Matching Program and use the NMS code designated for the International PGY1 Program at Mass General.


NMS Codes:

  • PGY1 Pharmacy Residency (General Track): 180513

  • PGY1 Pharmacy Residency (International Track): 180521
  • PGY1/2 Health-System Pharmacy Administration Residency: 263518
  • 
PGY2 Critical Care Pharmacy Residency: 648652

  • PGY2 Oncology Pharmacy Residency: 715660
  • PGY2 Emergency Medicine Residency: 751269
  • PGY2 Infectious Diseases Residency: 751455

 

PGY1 Pharmacy

Purpose

The Post Graduate Year 1 (PGY1) Pharmacy Residency program at Massachusetts General Hospital (MGH) builds on the Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.

Description

The PGY1 Pharmacy Residency Program is a directed experience in hospital practice and general pharmacotherapy. The MGH PGY1 program prepares individuals to practice as a clinical generalist or to pursue clinical specialty training through a variety of PGY2 residencies. Our mission is to provide a dynamic, goal-oriented environment to develop a well-rounded clinical expert, educator and leader, and to assure each resident is thoroughly trained in the provision of individualized direct patient care, clinical and didactic teaching, practice-based research, and patient-centric pharmacy leadership.

Throughout the year, the program reinforces the knowledge, thought processes and confidence for residents to provide pharmaceutical care to an assortment of patient populations. Residents gain experience in all pharmacy programs and services by working as an autonomous pharmacist within the pharmacy operations and longitudinal oversight of medication order review, physician order verification, and medication preparation, all while delivering comprehensive clinical pharmacy services. Through a range of experiences, the PGY1 resident develops independent practice skills and pharmacy leadership.

We currently offer eight positions for the PGY1 Pharmacy Residency. Seven positions are for the general track and one position is for the international track.

Note for International Applicants:

Only International applicants who have completed a pharmacist training program affiliated with MCPHS University can apply to the International Track and will be considered based on the merits of his/her application.

If an International applicant is not from one of these training programs, he/she is welcome to apply to the General Track if they are eligible to work in the US from June 2017 to June 2018 and will be considered based on the merits of his/her application.

Program Goals

  • In collaboration with the health care team, provide safe and effective patient care to a diverse range of patients, including those with multiple co-morbidities, high-risk medication regimens, and multiple medications following a consistent patient care process
  • Ensure continuity of care during patient transitions between care settings
  • Prepare, dispense, and manage medications to support safe and effective drug therapy for patients
  • Demonstrate ability to manage formulary and medication-use processes, as applicable to the organization
  • Demonstrate ability to evaluate and investigate practice, review data and assimilate scientific evidence to improve patient care and/or the medication-use system
  • Demonstrate leadership skills
  • Demonstrate management skills
  • Provide effective medication and practice-related education to patients, caregivers, health care professionals, students, and the public (individuals and groups)
  • Effectively employ appropriate preceptor roles when engaged in teaching students, pharmacy technicians or fellow health care professionals

Learning Experiences

The first month of residency is an orientation to the Department of Pharmacy, after a 1.5-day hospital orientation. Activities include competency lectures on basic clinical skills, training on the MGH computerized order entry system, and side-by-side decentralized and operational training with pharmacy preceptors. Additionally, residents will understand the structure of the Residency Program Design and Conduct, which is the backbone of how residency training is put into action.

Required Learning Experiences: (5)

  • Orientation
  • General Pediatrics
  • Internal Medicine
  • Pharmacy Administration
  • Transitions of Care

Selective Learning Experiences: (2)

  • Specialty medicine (select one)
    • Cardiology
    • Medical Oncology
    • Neurology
    • Solid Organ Transplantation
  • Critical care (select one)
    • Cardiac Intensive Care
    • Cardiac Surgical Intensive Care
    • Medical Intensive Care
    • Neurosciences Intensive Care
    • Surgical Intensive Care

Elective Learning Experiences:

  • Any of the above Selective Learning Experiences are available as elective if not chosen as a Selective Learning Experience
  • Advanced Internal Medicine
  • Ambulatory oncology
  • Burn ICU/Plastics
  • Emergency Medicine Observation
  • Focused Drug Policy
  • Emergency Medicine
  • ED Observation
  • Infectious Diseases
  • Hematopoietic Stem Cell Transplantation
  • Leukemia
  • Medication Safety
  • Neonatal Critical Care
  • Pediatric Critical Care
  • Substance Use Disorders

Longitudinal Experiences:

  • Clinical trials Pharmacy
  • Cystic Fibrosis Consult Pager
  • Medication Use Evaluations and Formulary Reviews
  • Emergency response with ACLS certification
  • Research project and manuscript development
  • Resident officer positions and committees
  • Advanced Pharmacy Practice Experience student precepting
  • Teaching and Learning Seminar Certificate opportunity at Northeastern University School of Pharmacy (optional)

Contact Information

Tasleem Spracklin, PharmD, BCPS
Clinical Pharmacist, Internal Medicine
Director, PGY1 Pharmacy Residency
TSpracklin@mgh.harvard.edu

Jonathan H. Sin, PharmD, BCPS
Clinical Pharmacist – Surgical/Trauma ICU
Coordinator, PGY2 Critical Care Pharmacy Residency
JSIN@mgh.harvard.edu

Ronak Gandhi, PharmD
Clinical Pharmacist – Infectious Diseases
Coordinator, PGY2 Infectious Diseases Pharmacy Residency, PGY1 Pharmacy Residency
RGGANDHI@mgh.harvard.edu

PGY2 Critical Care

Purpose

This PGY2 pharmacy residency program builds on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advances or specialized practice. PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).

Description

The PGY2 residents who complete this ASHP-accredited residency will provide pharmaceutical care in many patient care environments, trained to meet the challenges of current and future pharmacy practice. Graduates of the program will be prepared to function as independent practitioners in an adult intensive care unit as a critical care clinical pharmacist and have skills that will allow them to establish an area of specialty in cardiology, medicine, neurology, surgery and trauma management. Our graduates follow a personal philosophy of practice, have the ability to monitor and improve their own performance, and are committed to direct patient care and the pharmacy profession.

The accredited PGY2 Critical Care Pharmacy Residency Program adheres to the regulations and standards outlined in the ASHP Regulations on Accreditation of Pharmacy Residencies and the ASHP Accreditation Standard for Postgraduate Year Two (PGY2) Pharmacy Residency Programs.

We currently offer one position for the PGY2 Critical Care Pharmacy Residency.

Program Goals

  • Optimize outcomes in critically-ill patients by applying evidence-based medication therapy as an integral member of the interdisciplinary team
  • Participate effectively, efficiently and independently in the management of medical emergencies
  • Conduct and take ownership of a critical care research project from the initial concept/design to the preparation of a final publication-worthy manuscript
  • Demonstrate leadership and practice management skills and exhibit essential personal skills of a practice leader
  • Participate in the health-system formulary process for pharmacotherapeutic agents used in critically-ill patients
  • Establish excellence in the provision of training including preceptorship of pharmacy students and development of educational activities for healthcare professionals and trainees
  • Display attributes required to function in an academic setting and exercise teaching skills essential to pharmacy faculty

Learning Experiences

The first month of residency is an orientation to the Department of Pharmacy, after a 1.5-day hospital orientation. Activities include competency lectures on basic clinical skills, electronic health record (Epic®) training, and side-by-side decentralized training with clinical pharmacy preceptors. Additionally, residents will understand the structure of the Residency Learning System, which is the backbone of how residency training is put into action.

Core Learning Experiences:

  • Orientation
  • Medical Intensive Care (two months)
  • Surgical Intensive Care (two months)
  • Cardiac Intensive Care
  • Neurosciences Intensive Care
  • Cardiac Surgical Intensive Care
  • Emergency Medicine

Elective Learning Experiences:

  • Burn Intensive Care
  • Infectious Diseases
  • Neonatal Intensive Care
  • Pediatric Intensive Care
  • Other experiences based on the resident’s interest

Longitudinal Experiences:

  • Co-chair of the Critical Care Pharmacist Forum
  • Emergency Response
  • Pharmacy practice experience: decentralized clinical operations
  • Research project and manuscript development
  • Resident officer positions and committees (optional)
  • Residents teaching seminar / teaching certificate at Northeastern University School of Pharmacy (optional)

Contact Information

Russel Roberts, PharmD, FCCM, BCCCP
Clinical Pharmacy Manager, Cardiology, Critical Care and Emergency Medicine Services
Director, PGY2 Critical Care Pharmacy Residency
RJRoberts@mgh.harvard.edu

Kristy Phillips, PharmD, BCPS, BCCCP
Clinical Pharmacist – Medical Intensive Care Unit
Coordinator, PGY2 Critical Care Pharmacy Residency
KMPHILLIPS@mgh.harvard.edu

Program Leadership and Contact Information

Dr. Kristy Phillips, PharmD, BCPS, BCCPS serves as the Coordinator for the PGY2 Critical Care Residency Program at Massachusetts General Hospital.  Kristy is originally from Syracuse, New York, and graduated from Northeastern University with her Doctor of Pharmacy degree in 2010. Kristy completed a PGY1 Pharmacy residency at Kingsbrook Jewish Medical Center in Brooklyn, NY. She is board certified in Pharmacotherapy (BCPS) and Critical Care Pharmacotherapy (BCCCP).  Kristy is currently a Clinical Pharmacist in the Medical ICU at Massachusetts General Hospital.

PGY2 Transplant

Purpose

This PGY2 pharmacy residency program builds on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advances or specialized practice. PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).

Description

The PGY2 residents who complete this ASHP-accredited residency will provide pharmaceutical care in many patient care environments, trained to meet the challenges of current and future pharmacy practice. Graduates of the program will be prepared to function as independent practitioners in an adult intensive care unit as a critical care clinical pharmacist and have skills that will allow them to establish an area of specialty in cardiology, medicine, neurology, surgery and trauma management.

The accredited Transplant PGY2 Pharmacy Residency Program adheres to the regulations and standards outlined in the ASHP Regulations on Accreditation of Pharmacy Residencies and the ASHP Accreditation Standard for Postgraduate Year Two (PGY2) Pharmacy Residency Programs.

We currently offer one position for the PGY2 Transplant Pharmacy Residency.

Program Goals

  • Optimize outcomes in transplant recipients by providing evidence-based medication therapy as an integral member of the interdisciplinary team
  • Conduct and take ownership of a transplant focused research and quality improvement project
  • Demonstrate leadership and practice management skills and exhibit essential personal skills of a practice leader
  • Participate in the health-system formulary process for pharmacotherapeutic agents used in solid organ transplant recipients
  • Demonstrate excellence in the provision of training, preceptorship, or educational activities for health care professionals and health care professionals in training
  • Develop an evidence-based approach when providing transplant medication-related information
  • Demonstrate the ability to provide appropriate evidence-based recommendations for both donors and transplant recipients in both the acute care and ambulatory settings
  • Display attributes required to function in an academic setting and exercise teaching skills essential to pharmacy faculty

Learning Experiences

The first month of residency is an orientation to the Department of Pharmacy, after a 1.5-day hospital orientation. Activities include competency lectures on basic clinical skills, electronic health record (Epic®) training, and side-by-side decentralized training with clinical pharmacy preceptors. Additionally, residents will understand the structure of the Residency Learning System, which is the backbone of how residency training is put into action.

Core Learning Experiences:

  • Acute Care Kidney Transplantation
  • Acute Care Liver Transplantation
  • Acute Care Heart Transplantation
  • Acute Care Lung Transplantation
  • Ambulatory Care (choice of organ)

Elective Learning Experiences:

  • Immunocompromised Infectious Diseases
  • Surgical ICU
  • Bone marrow transplant
  • Cardiac surgery ICU
  • Advanced Heart Failure (MCS/LVAD)
  • Advanced Acute Care Transplant (choice of organ)
  • Hepatology
  • Pediatric transplant
  • Other experiences based on the resident’s interest

Longitudinal Experiences:

  • Medication Safety Event Monitoring
  • Emergency Response
  • Pharmacy practice experience: decentralized clinical operations
  • Research project and manuscript development
  • Resident officer positions and committees (optional)
  • Residents teaching seminar / teaching certificate at Northeastern University School of Pharmacy (optional)

Contact Information

Christin Rogers (Marks) PharmD, BCPS, FAST, FCCP
Director, PGY2 Transplant Pharmacy Residency
crogers3@mgh.harvard.edu

Thais Gift, PharmD, BCPS
Clinical Pharmacist – Solid Organ Transplant
Coordinator, PGY2 Transplant Pharmacy Residency
tgift@partners.org

PGY2 Oncology

This program has filled the residency position through the early commitment process for the 2019-2020 residency year. Thank you for your interest.

Purpose

This PGY2 pharmacy residency program builds on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advances or specialized practice. PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).

Description

The PGY2 residency in oncology pharmacy is designed to transition PGY1 residency graduates from generalist practice to specialized practice focused on the care of patients with cancer. Following completion of the PGY2 residency, graduates will be equipped to meet the challenges of current and future oncology pharmacy practice. Residency graduates will be prepared to participate as integral members of the interdisciplinary teams caring for individuals with cancer in both inpatient and outpatient settings, and assume responsibility for pharmaceutical care.

Graduates will gain significant knowledge of neoplastic diseases, cancer-related and cancer treatment-related disorders and supportive care/palliative care management. Graduates will also acquire knowledge of the preparation and distribution of anti-cancer medications including safe handling and disposal of hazardous substances.

Overall, graduates will gain experience participating on interdisciplinary teams to successfully serve healthcare organizations as a valuable resource for information about anti-cancer medications and decision-making affecting the care of patients with cancer.

We currently offer one position for the PGY2 Oncology Pharmacy Residency.

Program Educational Goals

  • In collaboration with the health care team, provide comprehensive medication management to oncology patients following a consistent patient care process.
  • Ensure continuity of care during transitions of oncology patients between care settings.
  • Manage and facilitate delivery of medications to support safe and effective drug therapy for oncology patients.
  • Demonstrate ability to manage formulary and medication-use processes for oncology patients, as applicable to the organization.
  • Demonstrate ability to conduct a quality improvement or research project.
  • Demonstrate management skills in the provision of care for oncology patients.
  • Provide effective medication and practice-related education to oncology patients, caregivers, health care professionals, students, and the public (individuals and groups).
  • Effectively employ appropriate preceptor roles when engaged in teaching students, pharmacy technicians, or fellow health care professionals in oncology.
  • Appropriately manage oncology investigational drugs and oncology investigational drug services.
  • Manage and improve the medication-use process in oncology patient care areas
  • Demonstrate excellence in the provisions of training or educational activities for health care professionals and health care professionals in training
  • Assume an active role in patient education activities: including direct patient counseling, adherence/knowledge assessment and development of education materials
  • Promote health improvement, wellness and cancer prevention
  • Sustain ongoing development of expertise and professionalism in the practice of oncology pharmacy
  • Conduct oncology pharmacy practice research
  • Function effectively in oncology settings participating in clinical investigations

Learning Experiences

The first month of residency is an orientation to the Department of Pharmacy, after a 1.5-day hospital orientation. Activities include competency lectures on basic clinical skills, training on the MGH computerized order entry system, and side-by-side training with clinical pharmacy preceptors. Additionally, residents will understand the structure of the Residency Learning System, which is the backbone of how residency training is put into action.

Core Learning Experiences:

  • Orientation
  • Medical Oncology
  • Hematopoietic Stem Cell Transplant
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Breast Oncology
  • Thoracic Oncology
  • Gastrointestinal Oncology
  • Genitourinary and Gynecologic Oncology
  • Melanoma
  • Pediatric Oncology

Elective Learning Experiences:

  • Palliative Care
  • Infectious Disease

Longitudinal Experiences:

  • Pharmacy practice experience – decentralized inpatient clinical operations and ambulatory oncology practice
  • Oncology Stewardship and Drug Policy
  • Oncology Pharmacy Management and Medication Safety
  • Education Series (includes weekly BCOP discussions)
  • Oncology clinical trials
  • Research project and manuscript development
  • Residents teaching seminar / teaching certificate at Massachusetts College of Pharmacy and Health Sciences University (optional)
  • Resident officer positions (optional)

Contact Information

Gayle Blouin, PharmD, BCOP
Director, PGY2 Oncology Pharmacy Residency
GBlouin@mgh.harvard.edu

PGY2 Emergency Medicine

This program has filled the residency position through the early commitment process for the 2019-2020 residency year. Thank you for your interest.

Purpose

The PGY2 emergency medicine (EM) pharmacy residency program at Massachusetts General Hospital (MGH) builds on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advanced or specialized practice. PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into provision of patient care that improves medication therapy. Residents who successfully complete the accredited PGY2 EM pharmacy residency at MGH will possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).

Description

The ASHP-Accredited PGY2 EM Pharmacy Residency at MGH began in 2017. Residents will learn the skills to establish an area of specialty in emergency medicine, critical care, infectious diseases, toxicology, trauma management, and education. MGH offers a dynamic learning environment including a close partnership with the Harvard Affiliated Emergency Medicine Residency program (HAEMR) and the regional poison center. The resident will play an active role in clinical and administrative EM initiatives. Teaching experience is provided through Departments of Pharmacy and EM conferences/symposia, didactic teaching in the HAEMR program, ASHP clinical pearls, pharmacy students and residents’ preceptorship, and an optional teaching certificate program at Northeastern University Bouve School of Pharmacy (optional). Finally, residents contribute to local and system-wide interdisciplinary committees pertaining to stroke care, sepsis management, emergency preparedness, and quality and safety.

We currently offer one position for the PGY2 EM Pharmacy Residency.

Program Goals

The resident will complete the following ASHP-established outcomes:

  • Demonstrate leadership and practice management skills
  • Optimize the outcomes of EM patients by providing evidence-based medication therapy as an integral part of an interdisciplinary team
  • Demonstrate excellence in the provision of training, including preceptorship, or educational activities for health care professionals and health care professionals in training
  • Demonstrate the skills necessary to conduct an EM pharmacy research project
  • Develop an evidence-based approach when providing EM medication-related information
  • Participate in the management of medical emergencies
  • Describe the role of the poison center or medical toxicologist in the care of the toxicology patient
  • Demonstrate the ability to provide appropriate evidenced based recommendations for the patient in need of toxicologic intervention in the ED setting

Learning Experiences

The first month of residency is an orientation to the Department of Pharmacy, after a 1.5-day hospital orientation. Activities include competency lectures on basic clinical skills, training on the MGH computerized order entry system, and side-by-side decentralized training with clinical pharmacy preceptors. Additionally, residents will understand the structure of the Residency Learning System, which is the backbone of how residency training is put into action.

Core Learning Experiences:

  • Orientation
  • Adult EM
  • Medical ICU
  • Pediatric EM/ICU
  • ED Administration
  • Toxicology
  • Pediatric ICU/Emergency Medicine
  • ED Observation
  • Cardiology/CCU
  • Emergency Medical Service
  • Emergency Medicine Precepting

Elective Learning Experiences:

  • Infectious Diseases
  • Surgical ICU

Longitudinal Experiences:

  • Emergency response
  • EM Pharmacist Forum
  • Pharmacy practice experience: decentralized clinical operations
  • Research project and manuscript development
  • Medication Use Evaluation
  • Residents Teaching Seminar/Certificate at Northeastern University Bouve College of Health Sciences (optional)
  • Resident officer positions (optional)

Contact Information

Bryan D. Hayes, PharmD, DABAT, FAACT, FASHP
Manager of EM and Overnight Pharmacy Services
Director, PGY2 Emergency Medicine Pharmacy Residency
BDHayes@mgh.harvard.edu

Lanting Fuh, PharmD, BCPS
Clinical Pharmacist - Emergency Medicine
Coordinator, PGY2 Emergency Medicine Pharmacy Residency
LFUH@mgh.harvard.edu

PGY2 Infectious Diseases

Purpose

This PGY2 pharmacy residency program builds on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advances or specialized practice. PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).

Description

The ASHP-Accredited PGY2 Infectious Diseases Pharmacy Residency at MGH began in 2017. This dynamic specialty residency offers residents a range of learning experiences to develop critical skills in infectious diseases pharmacotherapy.  Residents work collaboratively with pharmacy preceptors and infectious diseases fellows and faculty (5 general adult, 1 transplant and 1 pediatric ID consult services) to deliver and ensure optimal treatments and outcomes.  The resident will play an active role in clinical and administrative antimicrobial stewardship initiatives across all hospital departments. Trainees also play an active role in clinical and administrative antimicrobial stewardship initiatives across all hospital departments. Participation in the pharmacy department and ID division active learning opportunities (e.g. case conference, pharmacy teaching seminar, and medicine grand rounds) provides residents with tailored learning environments to excel and develop teaching and leadership skills.  Teaching experience is provided through pharmacy and ID division group discussions, pharmacy students and residents’ preceptorship, and an optional teaching certificate program at Northeastern University School of Pharmacy (optional). Finally, residents contribute to local and system-wide interdisciplinary committees pertaining to infectious diseases management, antimicrobial stewardship, and antimicrobial usage.

We currently offer one position for the PGY2 Infectious Diseases Pharmacy Residency.

Program Goals

The resident will complete the following ASHP-established outcomes:

  • Promote health improvement, wellness, and the prevention of infectious diseases.
  • Optimize the outcomes of individuals with an infectious disease by providing evidence-based, patient-centered medication therapy as an integral member of an interdisciplinary team or as an independent clinician.
  • Manage and improve anti-infective-use processes.
  • Demonstrate excellence in the provision of educational activities for health care professionals and health care professionals in training centering on optimizing anti-infective pharmacotherapy.
  • Serve as an authoritative resource on the optimal use of medications used to treat individuals with an infectious disease.
  • Demonstrate leadership and practice management skills.
  • Conduct infectious diseases pharmacy practice research.

Learning Experience:

The first month of the residency is an orientation to the Department of Pharmacy, after a 1.5-day hospital orientation. Activities include competency lectures on basic clinical skills, training on the Mass General computerized order entry system, and side-by-side decentralized training with clinical pharmacy preceptors. Additionally, residents will understand the structure of the Residency Learning System, which is the backbone of how residency training is put into action.

Core Learning Experiences:

  • Orientation
  • General Adult Infectious Diseases
  • Infectious Disease Specialist (attending-only team)
  • Transplant Infectious Diseases
  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Clinical Microbiology Laboratory and Infection Control

Elective Learning Experiences:

  • Adult Critical Care - medical or surgical
  • Bone Marrow Transplant
  • Emergency Medicine
  • Internal Medicine
  • Drug Policy

Longitudinal Experiences:

  • Antimicrobial Stewardship
  • HIV/ID clinic
  • MUE Drug Policy
  • Outpatient Parenteral Antimicrobial Therapy
  • Emergency response with BLS/ACLS certification
  • Pharmacy practice experience: decentralized clinical operations
  • Cystic fibrosis and aminoglycoside consult pager
  • Research project and manuscript development
  • Residents teaching seminar / teaching certificate at Northeastern University School of Pharmacy (optional)
  • Resident officer positions (optional)

Contact Information

Ramy Elshaboury, PharmD, BCPS-AQ ID
Clinical Manager – Infectious Diseases, Surgery, Solid Organ Transplant
Director, PGY2 Infectious Diseases Pharmacy Residency
RElshaboury@mgh.harvard.edu

Ronak Gandhi, PharmD
Clinical Pharmacist – Infectious Diseases
Coordinator, PGY2 Infectious Diseases Pharmacy Residency, PGY1 Pharmacy Residency
RGGANDHI@mgh.harvard.edu

PGY1/PGY2 Pharmacy Admin

PGY-1/PGY-2 Health-System Pharmacy Administration Residency Program

Purpose

The purpose of the program is to prepare graduates to serve in various leadership roles within an academic medical center health-system pharmacy department.

Description

The PGY-1/PGY-2 Health-System Pharmacy Administration (HSPA) Residency program is a 24-month program at Massachusetts General Hospital (MGH) with a combined Masters’ Degree in Pharmaceutical Sciences with a specialization in Health-System Pharmacy Administration from the University of North Carolina (UNC) Eshelman School of Pharmacy (#1 ranked pharmacy school in the country). 

In the first year of the program, residents will complete the same requirements of the MGH PGY-1 pharmacy residency program, supplemented with the MS degree. Our mission is to provide a dynamic, goal-oriented environment to develop a well-rounded clinical expert and to assure each resident is thoroughly trained in the provision of individualized direct patient care, clinical and didactic teaching, practice-based research and patient-centric pharmacy leadership. The PGY-1 year will develop the resident into an independent generalist practitioner with a strong clinical foundation. After completion of the first year of residency, the resident will receive a PGY-1 residency certificate.  

In the second year of the program, residents work closely with the entire Mass General Department of Pharmacy Leadership Team and hospital administrators to develop competence in clinical leadership, pharmacy operations, budgeting and finance, medication safety, drug use policy, regulatory affairs, process improvement, pharmacy informatics and enterprise-level management. The second-year electives are customizable to each resident's interests and career goals. Additionally, the resident can participate in a corporate pharmacy leadership role within Partners Healthcare, founded by both Massachusetts General Hospital and Brigham and Women’s Hospital and includes 10 additional community hospitals within the system.

The MGH PGY-1/PGY-2 Health-System Pharmacy Administration Residency will follow all standards and regulations outlined in the American Society of Health-System Pharmacists (ASHP) Regulations on Accreditation of Pharmacy Residencies and the ASHP Accreditation Standard for Postgraduate Year Two (PGY-2) Pharmacy Residency Programs. The residency program will be seeking accreditation status within the first year of the program.

We currently offer one position for the combined PGY-1/PGY-2 Health-System Pharmacy Administration Residency Program.

The Master of Science Degree in Pharmaceutical Sciences is offered in collaboration with the University of North Carolina Hospitals, Duke University Health System, Wake Forest Baptist Health, Mission Hospitals, and Moses Cone Hospital. The core curriculum for the two-year MS in Pharmaceutical Sciences program with a specialization in health-system pharmacy administration consists of course work in advanced topics with human resource management, health-systems financial management, medication safety, quality improvement, and health-system pharmacy operations.

Program Goals

  • Prepare, dispense and manage medications to support safe and effective drug therapy for patients
  • Design, implement and manage a safe and effective medication-use system
  • Apply contemporary quality methodology to the management of pharmacy services
  • Lead and manage the health system pharmacy’s human resources
  • Manage the health system pharmacy financial performance within the context of the broader health system
  • Leverage technology and automated systems to optimize the medication-use system
  • Demonstrate personal leadership qualities and business acumen essential to operate effectively within the health system and advance the profession and practice of pharmacy
  • Attain board certification (BCPS)

Learning Experiences

The first month of the PGY-1 residency is an orientation to the Department of Pharmacy, after a 1.5-day hospital orientation. Activities include competency lectures on basic clinical skills, training on the Massachusetts General Hospital Epic® information system and side-by-side training with clinical pharmacy preceptors.

PGY-1 Core Learning Experiences:

Please review the MGH PGY-1 Residency webpage to review the Core, Selective, Elective, and Longitudinal learning experiences in the PGY-1 year which will be completed in addition to the UNC MS Degree. The PGY-1/PGY-2 HSPA resident will have 8 weeks of Pharmacy Administration learning experience in the first year.

PGY-2 Core Learning Experiences:

  • Executive/Enterprise Leadership (8 weeks)
  • Hospital Executive Rotation (2 weeks)
  • Clinical Leadership (6 weeks)
  • Advanced Pharmacy Operations (8 weeks)
  • Budgeting and Finance (4 weeks)
  • Quality, Compliance, and Regulatory Affairs (4 weeks)

PGY-2 Elective Learning Experiences:

  • Ambulatory Operations
  • Specialty Pharmacy
  • Pharmacy Informatics
  • Medication Safety
  • 340b Drug Program/Supply Chain
  • Clinical Trials Pharmacy
  • Retail Pharmacy Management
  • Other experiences based on the resident’s interest

PGY2 Longitudinal Experiences:

  • Administrator On-Call
  • Committee Chair
  • Supervisor responsibilities
  • Pharmacy Practice Experience – Central and Decentralized Clinical Services

Application Requirements:

  • Doctor of Pharmacy degree from an ACPE-accredited program
  • Eligible for licensure in Massachusetts
  • Application materials must be submitted through PhORCAS by December 31
    • Completed application
    • Formal letter of intent
    • Curriculum vitae
    • Official university/college transcripts
    • Three letters of recommendation through PhORCAS (at least 1 letter of recommendation needs to be from a clinical preceptor)
  • Complete a UNC Graduate School Application

Contact Information

Christopher R. Fortier, PharmD, FASHP
Chief Pharmacy Officer
Director, PGY-1/PGY-2 Health-System Pharmacy Administration Residency
cfortier@partners.org

Laura Meleis, PharmD, MS, BCPS
Assistant Director of Pharmacy – Quality, Compliance, and Regulatory Affairs
Coordinator, PGY-1/PGY-2 Health-System Pharmacy Administration Residency
LMELEIS@mgh.harvard.edu

Back to Top